We are live on
!
Find out more
ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
6 hedge funds and large institutions have $181K invested in ZyVersa Therapeutics in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
12% more capital invested
Capital invested by funds: $162K → $181K (+$19.7K)
1.22% more ownership
Funds ownership: 0.01% → 1.23% (+1.2%)
33% less funds holding
Funds holding: 9 → 6 (-3)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Holders
6
Holders Change
-3
Holders Change %
-33.33%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
–
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$452K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$52.5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$42.2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$9.2K |
Top Sellers
| 1 |
Walleye Capital
New York
|
-$128K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$16.1K |
| 3 |
CAC
Cowen and Company
New York
|
-$6.47K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.23K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$2.19K |